Spectris plc

Reported sales increased 6% to £570.2 million, while like-for-like sales increased 11%. Adjusted operating profit increased 6% to £72.3 million, with adjusted operating margin flat at 12.7%; like-for-like adjusted operating margin was down 60 basis points. Adjusted profit before tax was £70.3 million, adjusted EPS was 49.8p, and the interim dividend was 24.1p per share, up 5%. H1 cash conversion was 39% due to higher working capital and CapEx, net debt was £98.3 million at June 30, and return on gross capital employed improved to 13.8%. For the full year, management still expects high-single-digit organic sales growth and margin expansion, CapEx of £50 million to £60 million, around £20 million of SaaS costs for ERP rollout, additional R&D spend of £15 million versus the £10 million previously guided, a 22% tax rate, and working capital within 11% to 15%.

Andrew Heath framed the first half as continued execution of a strategy that has made Spectris more focused, profitable, resilient, and less cyclical. He emphasized strong demand, market share gains, increased investment in R&D, and operational self-help through the Spectris Business System, while noting that pricing already in the order book should support second-half margin expansion. His tone was confident and strategic, repeatedly pointing to a stronger balance sheet, sustainability-linked growth themes, and a business positioned to compound growth through the cycle.

Derek Harding focused on the bridge from reported results to cash and full-year expectations. He highlighted £570.2 million of sales, £72.3 million of adjusted operating profit, 12.7% margin, £70.3 million of adjusted PBT, and 49.8p adjusted EPS, then explained that cash conversion was depressed by £31.6 million of working-capital outflow and £31.6 million of CapEx, including the new PMS facility in Colorado. He also noted £6.8 million of transaction-related costs, £98.3 million of net debt, the £410 million Omega proceeds received in July, and said cash conversion should normalize toward 80% to 90% in future periods.

Analysts pressed on the higher R&D run rate, pricing discipline, margin cadence, China lockdown impacts, supply-chain risk, M&A pricing, and whether Industrial Solutions should be reorganized further. Management said R&D is now above 8% partly because Omega had little R&D and because engineering resources are still being used to solve supply-chain issues, but that the spend is generating better product vitality and market-share gains. On pricing, they said increases are sticking and that about 4% to 5% additional pricing should flow through in H2; on supply chain, electronics and semiconductor availability remain the biggest issues, especially for HBK and Red Lion. They also said Industrial Solutions will now run as three stand-alone businesses reporting directly to the CEO, giving flexibility for future portfolio decisions, while M&A remains active but valuations have not yet clearly reset.